Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.

McEvoy JP, Howe AC, Hogarty GE.

J Nerv Ment Dis. 1984 Jul;172(7):412-6.

PMID:
6144721
[PubMed - indexed for MEDLINE]
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

Overview of partial compliance.

Marder SR.

J Clin Psychiatry. 2003;64 Suppl 16:3-9. Review.

PMID:
14680412
[PubMed - indexed for MEDLINE]
4.

[If drugs are not taken - how different antipsychotics influence compliance of schizophrenic patients].

Schorr SG, Brouwers JR, Taxis K.

Fortschr Neurol Psychiatr. 2007 Aug;75(8):473-7. Review. German.

PMID:
17638181
[PubMed - indexed for MEDLINE]
5.

Partial response to antipsychotic treatment: the patient with enduring symptoms.

Emsley RA.

J Clin Psychiatry. 1999;60 Suppl 23:10-3. Review.

PMID:
10625194
[PubMed - indexed for MEDLINE]
6.

How much do novel antipsychotics benefit the patients?

Kasper S.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S71-7. Review.

PMID:
9690974
[PubMed - indexed for MEDLINE]
7.

First-episode schizophrenia: the importance of early intervention and subjective tolerability.

Kasper S.

J Clin Psychiatry. 1999;60 Suppl 23:5-9. Review.

PMID:
10625193
[PubMed - indexed for MEDLINE]
8.

Good medical practice in antipsychotic pharmacotherapy.

Peuskens J.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S35-41. Review.

PMID:
9690969
[PubMed - indexed for MEDLINE]
9.

[Incidence of the deficit form in refractory schizophrenia].

Samuelian JC.

Encephale. 1996 Jun;22 Spec No 2:19-23. Review. French.

PMID:
8767037
[PubMed - indexed for MEDLINE]
10.

Early detection and intervention in schizophrenia.

Linszen DH, Dingemans PM, Lenior ME, Scholte WF, de Haan L, Goldstein MJ.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S31-4. Review.

PMID:
9690968
[PubMed - indexed for MEDLINE]
11.

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria.

Gerlach J.

Ann Clin Psychiatry. 2002 Mar;14(1):47-57. Review.

PMID:
12046640
[PubMed - indexed for MEDLINE]
12.

Partial compliance in schizophrenia and the impact on patient outcomes.

Llorca PM.

Psychiatry Res. 2008 Nov 30;161(2):235-47. doi: 10.1016/j.psychres.2007.07.012. Epub 2008 Oct 11. Review.

PMID:
18849080
[PubMed - indexed for MEDLINE]
13.

Medication noncompliance in schizophrenia: codification and update.

Young JL, Zonana HV, Shepler L.

Bull Am Acad Psychiatry Law. 1986;14(2):105-22. Review.

PMID:
2873851
[PubMed - indexed for MEDLINE]
14.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Review. French.

PMID:
19250998
[PubMed - indexed for MEDLINE]
15.

Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.

Svestka J, Bitter I.

Neuro Endocrinol Lett. 2007 Feb;28 Suppl 1:95-116. Review.

PMID:
17262005
[PubMed - indexed for MEDLINE]
16.

[Pharmacotherapy for schizophrenia].

Fleischhacker WW, Hummer W.

Nervenarzt. 2006 Nov;77 Suppl 2:S77-97; S98. Review. German.

PMID:
17082927
[PubMed - indexed for MEDLINE]
17.

Conventional antipsychotic medications for schizophrenia.

Dixon LB, Lehman AF, Levine J.

Schizophr Bull. 1995;21(4):567-77. Review.

PMID:
8749885
[PubMed - indexed for MEDLINE]
Free Article
18.

The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.

Gerlach J.

J Clin Psychiatry. 1999;60 Suppl 23:20-4. Review.

PMID:
10625196
[PubMed - indexed for MEDLINE]
19.

[Compliance in therapy of schizophrenic patients with neuroleptics--an overview].

Mayer C, Soyka M.

Fortschr Neurol Psychiatr. 1992 Jun;60(6):217-22. Review. German.

PMID:
1353747
[PubMed - indexed for MEDLINE]
20.

Strategies for enhancing drug therapy of schizophrenia.

Schooler NR, Levine J.

Am J Psychother. 1983 Oct;37(4):521-32. Review.

PMID:
6140869
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk